VCMCVC Market Cap
Menu

Innovaccer valuation, funding and investors

Innovaccer works in healthcare data integration and activation, based in San Francisco, United States. Founded in 2014, it has about 1,630 employees.

VALUATION · TODAY
$4.57B +0% after Series F
Range $1.98B – $5.25B · Grade B
TODAY
+12 MO
$2.00B
$4.00B
$6.00B
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed
Seed
Seed $3.00M
Series A $15.6M
Series B $25.0M
Series C $70.0M
Series D $105M
Series E $150M
Series F $275M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY1,630 employees
−9%6m growth
−1%1y growth
+16%2y growth
1,000
2,000
Data from Jan 2021
TODAY
Predicted in 1 yr $4.57B +0% vs today
Predicted next raise $502M if a round comes
Winding-down probability 0%
Last round
Series F · $275M · Jan 2025
Valuation at last round
$3.45B
Headcount
1,630 · flat
Grade
B
Founded
2014
How VCMC values companies →

Innovaccer valuation today

VCMC values Innovaccer at $4.6B today, with a range of $2.0B to $5.3B and a grade of B. The valuation starts from its last funding round, a Series F round in Jan 2025.

Valuation by date (164 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Innovaccer: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2014$4.93M$1.79M – $13.5M$5.17M (+5%)before first round–unknownD0%
1 Feb 2014$4.95M$1.80M – $13.6M$5.19M (+5%)before first round–unknownD0%
1 Mar 2014$4.97M$1.81M – $13.6M$5.21M (+5%)before first round–unknownD0%
1 Apr 2014$4.99M$1.82M – $13.7M$5.23M (+5%)before first round–unknownD0%
1 May 2014$5.01M$1.82M – $13.8M$5.25M (+5%)before first round–unknownD0%
1 Jun 2014$5.03M$1.83M – $13.8M$5.27M (+5%)before first round–unknownD0%
1 Jul 2014$5.05M$1.84M – $13.9M$5.29M (+5%)before first round–unknownD0%
1 Aug 2014$5.07M$1.84M – $13.9M$5.31M (+5%)before first round–unknownD0%
1 Sep 2014$5.09M$1.85M – $14.0M$5.33M (+5%)before first round–unknownD0%
1 Oct 2014$5.11M$1.86M – $14.0M$5.35M (+5%)before first round–unknownD0%
1 Nov 2014$5.13M$1.87M – $14.1M$5.37M (+5%)before first round–unknownD0%
1 Dec 2014$5.15M$1.87M – $14.1M$5.39M (+5%)before first round–unknownD0%
1 Jan 2015$22.0M$11.0M – $87.7M$44.0M (+100%)after a round–unknownD0%
2 Jan 2015$22.0M$11.0M – $87.7M$44.0M (+100%)after a round–unknownD0%
28 Jan 2015$15.4M$10.1M – $46.9M$30.8M (+100%)after a round–unknownC0%
1 Feb 2015$15.5M$10.1M – $46.9M$30.8M (+98%)after a round–unknownC0%
1 Mar 2015$16.4M$10.1M – $46.9M$30.8M (+88%)after a round–unknownC0%
1 Apr 2015$17.4M$10.1M – $46.9M$30.8M (+77%)after a round–unknownC0%
1 May 2015$18.4M$10.1M – $46.9M$30.8M (+67%)after a round–unknownC0%
14 May 2015$15.7M$11.0M – $44.4M$31.3M (+100%)after a round–unknownC0%
1 Jun 2015$16.2M$11.0M – $44.4M$31.3M (+93%)after a round–unknownC0%
1 Jul 2015$17.2M$11.0M – $44.4M$31.3M (+82%)after a round–unknownC0%
1 Aug 2015$18.2M$11.0M – $44.4M$31.3M (+72%)after a round–unknownC0%
1 Sep 2015$19.3M$11.0M – $44.4M$31.3M (+62%)after a round–unknownC0%
1 Oct 2015$20.4M$11.0M – $44.4M$31.3M (+53%)after a round–unknownC0%
1 Nov 2015$21.7M$11.0M – $44.4M$31.3M (+44%)after a round–unknownC0%
1 Dec 2015$22.9M$11.0M – $44.4M$31.3M (+36%)after a round–unknownC0%
1 Jan 2016$24.3M$11.0M – $44.4M$31.3M (+29%)after a round–unknownC0%
1 Feb 2016$25.8M$11.0M – $44.4M$31.3M (+21%)after a round–unknownC0%
1 Mar 2016$27.3M$11.0M – $44.4M$31.3M (+15%)after a round–unknownC0%
1 Apr 2016$28.9M$11.0M – $44.4M$31.3M (+8%)after a round–unknownC0%
1 May 2016$30.6M$11.0M – $44.4M$31.3M (+2%)after a round–unknownC0%
1 Jun 2016$31.3M$10.7M – $44.4M$31.3M (0%)after a round–unknownC0%
1 Jul 2016$31.3M$10.2M – $44.4M$31.3M (0%)after a round–unknownC0%
1 Aug 2016$31.3M$9.65M – $44.4M$31.3M (0%)after a round–unknownC0%
11 Aug 2016$64.4M$45.3M – $164M$116M (+80%)after a round–unknownC0%
1 Sep 2016$66.6M$45.3M – $164M$116M (+74%)after a round–unknownC0%
1 Oct 2016$69.9M$45.3M – $164M$116M (+66%)after a round–unknownC0%
1 Nov 2016$73.5M$45.3M – $164M$116M (+57%)after a round–unknownC0%
1 Dec 2016$77.2M$45.3M – $164M$116M (+50%)after a round–unknownC0%
1 Jan 2017$81.1M$45.3M – $164M$116M (+43%)after a round–unknownC0%
1 Feb 2017$85.3M$45.3M – $164M$116M (+36%)after a round–unknownC0%
1 Mar 2017$89.2M$45.3M – $164M$116M (+30%)after a round–unknownC0%
1 Apr 2017$93.7M$45.3M – $164M$116M (+24%)after a round–unknownC0%
1 May 2017$98.4M$45.3M – $164M$116M (+18%)after a round–unknownC0%
1 Jun 2017$103M$45.3M – $164M$116M (+12%)after a round–unknownC0%
1 Jul 2017$109M$45.3M – $164M$116M (+7%)after a round–unknownC0%
1 Aug 2017$114M$45.3M – $164M$116M (+1%)after a round–unknownC0%
1 Sep 2017$116M$43.7M – $164M$116M (0%)after a round–unknownC0%
1 Oct 2017$116M$41.6M – $164M$116M (0%)after a round–unknownC0%
1 Nov 2017$116M$39.6M – $164M$116M (0%)after a round–unknownC0%
1 Dec 2017$116M$37.7M – $164M$116M (0%)after a round–unknownC0%
1 Jan 2018$116M$35.8M – $164M$116M (0%)after a round–unknownC0%
1 Feb 2018$116M$34.0M – $164M$116M (0%)after a round–unknownC0%
1 Mar 2018$116M$32.5M – $164M$116M (0%)after a round–unknownC0%
1 Apr 2018$116M$30.9M – $164M$116M (0%)after a round–unknownC0%
1 May 2018$116M$29.4M – $164M$116M (0%)after a round–unknownC0%
11 May 2018$163M$115M – $347M$245M (+50%)after a round–unknownB0%
1 Jun 2018$167M$115M – $347M$245M (+46%)after a round–unknownB0%
1 Jul 2018$173M$115M – $347M$245M (+42%)after a round–unknownB0%
1 Aug 2018$179M$115M – $347M$245M (+37%)after a round–unknownB0%
1 Sep 2018$185M$115M – $347M$245M (+32%)after a round–unknownB0%
1 Oct 2018$191M$115M – $347M$245M (+28%)after a round–unknownB0%
1 Nov 2018$198M$115M – $347M$245M (+24%)after a round–unknownB0%
1 Dec 2018$205M$115M – $347M$245M (+19%)after a round–unknownB0%
1 Jan 2019$212M$115M – $347M$245M (+15%)after a round–unknownB0%
1 Feb 2019$219M$115M – $347M$245M (+12%)after a round–unknownB0%
1 Mar 2019$226M$115M – $347M$245M (+8%)after a round–unknownB0%
1 Apr 2019$234M$115M – $347M$245M (+4%)after a round–unknownB0%
1 May 2019$242M$115M – $347M$245M (+1%)after a round–unknownB0%
1 Jun 2019$245M$111M – $347M$245M (0%)after a round–unknownB0%
1 Jul 2019$245M$107M – $347M$245M (0%)after a round–unknownB0%
1 Aug 2019$245M$102M – $347M$245M (0%)after a round–unknownC0%
1 Sep 2019$245M$97.7M – $347M$245M (0%)after a round–unknownC0%
1 Oct 2019$245M$93.6M – $347M$245M (0%)after a round–unknownC0%
1 Nov 2019$245M$89.6M – $347M$245M (0%)after a round–unknownC0%
1 Dec 2019$245M$85.8M – $347M$245M (0%)after a round–unknownC0%
1 Jan 2020$245M$82.1M – $347M$245M (0%)after a round–unknownC0%
1 Feb 2020$245M$78.6M – $347M$245M (0%)after a round–unknownC0%
15 Feb 2020$523M$368M – $964M$680M (+30%)after a round–unknownB0%
1 Mar 2020$529M$368M – $964M$680M (+29%)after a round–unknownB0%
1 Apr 2020$541M$368M – $964M$680M (+26%)after a round–unknownB0%
1 May 2020$553M$368M – $964M$680M (+23%)after a round–unknownB0%
1 Jun 2020$565M$368M – $964M$680M (+20%)after a round–unknownB0%
1 Jul 2020$577M$368M – $964M$680M (+18%)after a round–unknownB0%
1 Aug 2020$590M$368M – $964M$680M (+15%)after a round–unknownB0%
1 Sep 2020$604M$368M – $964M$680M (+13%)after a round–unknownB0%
1 Oct 2020$617M$368M – $964M$680M (+10%)after a round–unknownB0%
1 Nov 2020$631M$368M – $964M$680M (+8%)after a round–unknownB0%
1 Dec 2020$644M$368M – $964M$680M (+5%)after a round–unknownB0%
1 Jan 2021$659M$368M – $964M$680M (+3%)after a round630unknownB0%
1 Feb 2021$674M$368M – $964M$680M (+1%)after a round630unknownB0%
25 Feb 2021$1.3B$1.1B – $1.9B$1.7B (+30%)after a round630unknownA0%
1 Mar 2021$1.3B$1.1B – $1.9B$1.7B (+30%)after a round630unknownA0%
1 Apr 2021$1.3B$1.1B – $1.9B$1.7B (+27%)after a round630flatA0%
1 May 2021$1.4B$1.1B – $2.1B$1.8B (+31%)after a round870growingB0%
1 Jun 2021$1.4B$1.1B – $2.1B$1.8B (+28%)after a round870growingB0%
1 Jul 2021$1.5B$1.1B – $2.1B$1.8B (+24%)after a round870growingB0%
1 Aug 2021$1.5B$1.1B – $2.1B$1.8B (+21%)after a round870growingB0%
1 Sep 2021$1.5B$1.1B – $2.1B$1.8B (+17%)after a round870growingB0%
1 Oct 2021$1.6B$1.1B – $2.1B$1.8B (+14%)after a round870growingB0%
1 Nov 2021$1.6B$1.1B – $2.1B$1.8B (+11%)after a round870growingB0%
1 Dec 2021$1.7B$1.1B – $2.1B$1.8B (+8%)after a round870growingB0%
16 Dec 2021$3.2B$2.8B – $4.8B$4.2B (+30%)after a round870growingA0%
1 Jan 2022$3.2B$2.8B – $4.8B$4.2B (+28%)after a round870growingA0%
1 Feb 2022$3.3B$2.8B – $4.8B$4.2B (+26%)after a round870growingA0%
1 Mar 2022$3.4B$2.8B – $4.8B$4.2B (+23%)after a round870growingA0%
1 Apr 2022$3.5B$2.8B – $4.8B$4.2B (+20%)after a round870growingA0%
1 May 2022$3.5B$2.8B – $4.8B$4.2B (+18%)after a round870growingA0%
1 Jun 2022$3.6B$2.8B – $4.8B$4.2B (+15%)after a round870growingA0%
1 Jul 2022$3.7B$2.8B – $4.8B$4.2B (+13%)after a round870growingA0%
1 Aug 2022$3.8B$2.8B – $4.8B$4.2B (+10%)after a round870growingA0%
1 Sep 2022$3.9B$2.8B – $4.8B$4.2B (+8%)after a round870growingA0%
1 Oct 2022$3.9B$2.8B – $4.8B$4.2B (+6%)after a round870growingA0%
1 Nov 2022$4.0B$2.8B – $4.8B$4.2B (+3%)after a round870unknownA0%
1 Dec 2022$4.1B$2.8B – $4.8B$4.2B (+1%)after a round870unknownA0%
1 Jan 2023$4.2B$2.7B – $4.8B$4.2B (0%)after a round1,700unknownA0%
1 Feb 2023$4.2B$2.6B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Mar 2023$4.2B$2.5B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Apr 2023$4.2B$2.4B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 May 2023$4.2B$2.3B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Jun 2023$4.2B$2.2B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Jul 2023$4.2B$2.1B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Aug 2023$4.2B$2.0B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Sep 2023$4.2B$1.9B – $4.8B$4.2B (0%)after a round1,700unknownB0%
1 Oct 2023$2.6B$1.7B – $4.1B$1.9B (-27%)after a round1,300downB97%
1 Nov 2023$2.6B$1.6B – $4.1B$1.9B (-27%)after a round1,300downB97%
1 Dec 2023$2.5B$1.6B – $4.2B$1.8B (-28%)after a round1,300downB97%
1 Jan 2024$2.4B$1.5B – $4.2B$1.6B (-33%)after a round1,300downB97%
1 Feb 2024$2.3B$1.4B – $4.3B$1.5B (-33%)after a round1,300downB97%
1 Mar 2024$2.3B$1.3B – $4.3B$1.5B (-34%)after a round1,300downB97%
1 Apr 2024$2.2B$1.3B – $4.4B$1.5B (-34%)after a round1,300downC97%
1 May 2024$2.2B$1.2B – $4.4B$1.4B (-35%)after a round1,300downC97%
1 Jun 2024$2.1B$1.2B – $4.5B$1.4B (-36%)after a round1,300downC97%
1 Jul 2024$2.1B$1.1B – $4.5B$1.3B (-36%)after a round1,300downC97%
1 Aug 2024$2.1B$1.0B – $4.6B$1.4B (-34%)after a round1,400flatC89%
1 Sep 2024$2.2B$995M – $4.6B$1.5B (-33%)after a round1,400flatC82%
1 Oct 2024$2.3B$947M – $4.7B$1.6B (-32%)after a round1,400flatC76%
1 Nov 2024$2.3B$1.1B – $4.7B$1.6B (-30%)after a round1,500upC70%
1 Dec 2024$2.4B$1.1B – $4.8B$1.7B (-29%)after a round1,500upC64%
1 Jan 2025$2.3B$1.0B – $4.8B$1.7B (-26%)after a round1,500upC59%
10 Jan 2025$3.5B$3.0B – $5.2B$4.5B (+30%)after a round1,500upA0%
1 Feb 2025$3.5B$3.0B – $5.2B$4.5B (+28%)after a round1,500upA0%
1 Mar 2025$3.6B$3.0B – $5.2B$4.5B (+25%)after a round1,500upA0%
1 Apr 2025$3.7B$3.0B – $5.2B$4.5B (+23%)after a round1,500upA0%
1 May 2025$3.7B$3.0B – $5.2B$4.5B (+20%)after a round1,500upA0%
1 Jun 2025$3.8B$3.0B – $5.2B$4.5B (+17%)after a round1,500upA0%
1 Jul 2025$3.9B$3.0B – $5.2B$4.5B (+15%)after a round1,500upA0%
1 Aug 2025$4.0B$3.0B – $5.2B$4.6B (+13%)after a round1,614upA0%
1 Sep 2025$4.1B$3.0B – $5.2B$4.6B (+10%)after a round1,614upA0%
1 Oct 2025$4.2B$3.0B – $5.3B$4.6B (+8%)after a round1,651upA0%
1 Nov 2025$4.3B$3.0B – $5.3B$4.6B (+6%)after a round1,651upA0%
1 Dec 2025$4.4B$3.0B – $5.3B$4.6B (+3%)after a round1,651upA0%
1 Jan 2026$4.6B$3.0B – $5.3B$4.6B (+1%)after a round1,651upA0%
1 Feb 2026$4.6B$3.0B – $5.3B$4.6B (0%)after a round1,651upA0%
1 Mar 2026$4.6B$2.8B – $5.3B$4.6B (0%)after a round1,651flatB0%
1 Apr 2026$4.7B$2.9B – $5.4B$4.7B (0%)after a round1,796upB0%
1 May 2026$4.7B$2.9B – $5.4B$4.7B (0%)after a round1,783upB0%
1 Jun 2026$4.7B$2.5B – $5.4B$4.7B (0%)after a round1,783flatB0%
1 Jul 2026$4.7B$2.4B – $5.4B$4.7B (0%)after a round1,783flatB0%
1 Aug 2026$4.6B$2.2B – $5.3B$4.6B (0%)after a round1,710flatB0%
1 Sep 2026$4.6B$2.2B – $5.3B$4.6B (0%)after a round1,710flatB0%
1 Oct 2026$4.6B$2.0B – $5.3B$4.6B (0%)after a round1,630flatB0%
24 Oct 2026$4.6B$2.0B – $5.3B$4.6B (0%)after a round1,630flatB0%

Key facts about Innovaccer

Founded
2014
Headquarters
San Francisco, United States
Employees
about 1,630 -1% in a year
Total raised
$644M
Funding rounds
9
Last round
Series F Jan 2025

Innovaccer was founded in 2014 by Abhinav Shashank, Kanav Hasija and Sandeep Gupta.

Innovaccer funding history

Innovaccer has 9 funding rounds on record, from Jan 2015 to Jan 2025, $644M in total. The latest disclosed valuation is $3.45B post-money (Series F, Jan 2025).

  1. Series F 9 Jan 2025

    Led by B Capital; with M12, Tiger Global, Generation Investment Management, Kaiser Permanente Ventures, Danaher Ventures LLC, Banner Health, Schonfeld, Whale Rock Capital Management, Mubadala, OMERS, Dragoneer Investment Group, Steadview Capital, Avidity Partners.

    Sources: mobihealthnews.com, techcrunch.com, newnex.io and 1 more

    $275M

    $3.45B post-money

  2. Series E 15 Dec 2021

    Led by Mubadala Capital; with B Capital, M12, OMERS Private Equity, Dragoneer Investment Group, Steadview Capital, Tiger Global, Whale Rock Capital Management, Avidity Partners, Schonfeld Strategic Advisors.

    Sources: omersprivateequity.com, mobihealthnews.com, techcrunch.com and 1 more

    $150M

    $3.20B post-money

  3. Series D 24 Feb 2021

    Led by Tiger Global Management; with Steadview Capital, Dragoneer Investment Group, B Capital, Mubadala Capital, OMERS Growth Equity, M12, Generation Investment Management, Kaiser Permanente Ventures, Danaher Ventures LLC, Banner Health, Schonfeld, Whale Rock Capital Management.

    Sources: prnewswire.com, finsmes.com, fiercehealthcare.com and 1 more

    $105M

    $1.30B post-money

  4. Series C 14 Feb 2020

    Led by Tiger Global, Steadview Capital; with Dragoneer Investment Group, WestBridge, Mubadala, M12, B Capital, Generation Investment Management, Kaiser Permanente Ventures, Danaher Ventures LLC, Banner Health, Schonfeld, Whale Rock Capital Management, OMERS.

    Sources: prnewswire.com, mobihealthnews.com, hitconsultant.net and 1 more

    $70M

  5. Series B 10 May 2018

    Led by WestBridge Capital; with Lightspeed Venture Partners, B Capital, M12, Tiger Global Management, Generation Investment Management, Kaiser Permanente Ventures, Danaher Ventures LLC, Banner Health, Schonfeld, Whale Rock Capital Management, Mubadala Capital, OMERS, Dragoneer Investment Group, Steadview Capital.

    Sources: finsmes.com, prnewswire.com, finsmes.com

    $25M

  6. Series A 10 Aug 2016

    Led by Westbridge Capital Partners; with 500 Global, Six Sigma Academy, Start Smart Labs, B Capital, M12, Tiger Global Management, Generation Investment Management, Kaiser Permanente Ventures, Danaher Ventures LLC, Banner Health, Schonfeld, Whale Rock Capital Management, Mubadala Capital, OMERS, Dragoneer Investment Group, Steadview Capital.

    Sources: prnewswire.com, techcrunch.com, timesofindia.indiatimes.com and 1 more

    $16M

  7. Seed 13 May 2015

    Investors not disclosed.

    $3.0M

  8. Seed 27 Jan 2015

    With B Capital, M12, Tiger Global, Generation Investment Management, Kaiser Permanente Ventures, Danaher Ventures LLC, Banner Health, Schonfeld, Whale Rock Capital Management, Mubadala Capital, OMERS, Dragoneer Investment Group, Steadview Capital.

    Amount undisclosed

  9. Seed 1 Jan 2015

    With 500 Global.

    Sources: valueforstartups.in

    Amount undisclosed

Innovaccer investors

26 investors have backed Innovaccer; B Capital, Steadview Capital and Mubadala Capital and 4 more led at least one round.

What Innovaccer does

Innovaccer works in tech companies, with 14 recorded offerings and customers in healthcare, life sciences and public sector.

Innovaccer, Inc. is an American digital healthcare company that develops and provides AI-enabled solutions for healthcare data activation and automation. The company offers a platform that integrates enterprise healthcare data and applies artificial intelligence to automate administrative processes, support clinical and financial operations, and facilitate population health management. Innovaccer serves providers, payers, public sector organizations, and life sciences companies, and operates globally with offices in the United States, India, and the United Arab Emirates.

Description from Veridion's company data.

Products and services

  • Healthcare Data Integration and Activation
  • AI-Powered Healthcare Workflow Automation
  • Administrative Task Automation Solutions
  • Clinical and Financial Outcome Improvement Services
  • Population Health Management Solutions
  • Value-Based Care Enablement Services
  • Healthcare Data Analytics and Insights Generation
  • Healthcare Platform Development
  • Healthcare Technology Consulting Services
  • Provider and Payer Digital Transformation Services
  • Healthcare Operations Optimization Solutions
  • Patient Outcome Improvement Services
  • Healthcare Data Connectivity Solutions
  • Healthcare Workflow Automation Services

Markets

  • Healthcare
  • Life Sciences
  • Public Sector

Technology

  • AI-Driven Healthcare Data Activation
  • AI-Powered Healthcare Workflow Automation

Business model

  • Business-to-Business
  • Software-as-a-Service
  • Enterprise

Industry codes (NAICS)

  • 513210 Software Publishers 100% match

Questions about Innovaccer

What is Innovaccer worth?

Valuation $4.6B (range $2.0B to $5.3B), as of 24 Oct 2026. The last disclosed valuation was $3.45B (Series F, Jan 2025).

Has Innovaccer raised money?

Innovaccer has 9 funding rounds on record, from Jan 2015 to Jan 2025, $644M in total. The latest disclosed valuation is $3.45B post-money (Series F, Jan 2025).

Who has invested in Innovaccer?

B Capital, Steadview Capital, Mubadala Capital, Tiger Global, Tiger Global Management and WestBridge Capital, and 20 more. Lead investors include B Capital, Steadview Capital, Mubadala Capital and Tiger Global.

How many people work at Innovaccer?

About 1,630, down 1% over the last year. Headcount grew from 630 in Jan 2021 to 1,630 in Sep 2026.

What does Innovaccer do?

Innovaccer works in tech companies, with 14 recorded offerings and customers in healthcare, life sciences and public sector. Its main offerings are healthcare data integration and activation, AI-Powered healthcare workflow automation and administrative task automation solutions.

When was Innovaccer founded, and where is it based?

Innovaccer was founded in 2014 and is based in San Francisco, United States. It has about 1,630 employees, down 1% over the last year.